Form 4: Protagonist Therapeutics CEO Reports Stock Gift

CEO Dinesh V. Patel gifted 1,460 shares of Protagonist Therapeutics common stock to family and friends.

Summary

• Dinesh V. Patel, President and CEO of Protagonist Therapeutics, Inc., executed a bona fide gift of 1,460 shares of common stock.
• The transaction occurred on April 23, 2026.
• Following this transaction, the reporting person maintains beneficial ownership of 523,478 shares of common stock.
• The shares were disposed of at a price of $0.00, consistent with a gift transaction.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the transaction is a personal gift and does not signal a change in corporate strategy or financial health.

Positives

• The transaction represents a charitable or personal gift rather than a market-based divestment, indicating no change in the CEO's long-term commitment to the company.

Negatives

• The total number of shares held by the CEO has decreased by 1,460 units.

Risks

• None identified; this is a routine disclosure of a personal gift.

Future Outlook

No forward-looking guidance or strategic updates were provided in this filing.

Industry Context

StockSavvy.ai notes that insider gift filings are standard regulatory disclosures and generally do not reflect changes in management's outlook on company performance or industry positioning.

Comparison to Industry Standards

• The filing is consistent with standard SEC reporting requirements for executive officers under Section 16(a) of the Securities Exchange Act.

Related Party Transactions

• The filing discloses a gift of securities to family and friends.

Stakeholder Impact

• Minimal impact on shareholders as the transaction is a non-market transfer.

Key Dates

Keywords

Protagonist Therapeutics, PTGX, Insider Trading, Form 4, Dinesh Patel, Biotech